Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle M Dugan

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Annals of Surgical Oncology|August 22, 2024
Hepatic and Overall Progression-Free Survival After Percutaneous Hepatic Perfusion (PHP) as First-Line or Second-Line Therapy for Metastatic Uveal MelanomaHelana Ghali, Michelle M Dugan, Shaliz Aflatooni, et al.
Cancer Control : Journal of the Moffitt Cancer Center|October 25, 2023
Grade of Primary Cutaneous Leiomyosarcoma Dictates Risk for Metastatic Spread and Disease-Specific MortalityMichael J Carr, James Sun, William A Adams, et al.
Annals of Surgical Oncology|April 25, 2025
The Use of Radar-Guided Localization to Identify Metastatic Melanoma After Neoadjuvant ImmunotherapyMichelle M Dugan, Kate E Beekman, Danielle K DePalo, et al.
The American Journal of Dermatopathology|March 20, 2026
Associations Between Pigmentation and the Clinicopathologic and Immune Landscape of MelanomaHelana Ghali, Ayah N Al-Bzour, Aleena Boby, et al.
Journal of the National Cancer Institute|June 15, 2026
Utility of recurrence-based surrogate endpoints for survival in adjuvant cancer trials: evidence from melanomaSophie E Orme, Serigne N Lo, Robyn P Saw, et al.
Annals of Surgical Oncology|November 22, 2024
Impact of Social Determinants of Health on Melanoma Nodal Surveillance in a Multi-institutional CohortKelsey B Montgomery, M Chandler McLeod, Danielle K DePalo, et al.
Annals of Surgical Oncology|December 8, 2025
ASO Visual Abstract: Recurrence and Survival Outcomes in Patients with Primary Merkel Cell Carcinoma with Positive, Negative or Not Performed Sentinel Lymph Node BiopsyMichelle M Dugan, Caitlyn Balsay-Patel, Nicholas Chin, et al.
Annals of Surgical Oncology|December 11, 2024
ASO Visual Abstract: Impact of Social Determinants of Health on Melanoma Nodal Surveillance in a Multi-Institutional CohortKelsey B Montgomery, M Chandler McLeod, Danielle K DePalo, et al.
Annals of Surgical Oncology|October 31, 2025
Recurrence and Survival Outcomes in Patients with Primary Merkel Cell Carcinoma with Positive, Negative, or Not Performed Sentinel Lymph Node BiopsyMichelle M Dugan, Caitlyn Balsay-Patel, Nicholas Chin, et al.
Cancer|November 10, 2024
A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first-line treatment for patients with melanoma in-transit metastasesDanielle K DePalo, Michelle M Dugan, Syeda Mahrukh Hussnain Naqvi, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Annals of Surgical Oncology|August 22, 2024
Hepatic and Overall Progression-Free Survival After Percutaneous Hepatic Perfusion (PHP) as First-Line or Second-Line Therapy for Metastatic Uveal MelanomaHelana Ghali, Michelle M Dugan, Shaliz Aflatooni, et al.
Cancer Control : Journal of the Moffitt Cancer Center|October 25, 2023
Grade of Primary Cutaneous Leiomyosarcoma Dictates Risk for Metastatic Spread and Disease-Specific MortalityMichael J Carr, James Sun, William A Adams, et al.
Annals of Surgical Oncology|April 25, 2025
The Use of Radar-Guided Localization to Identify Metastatic Melanoma After Neoadjuvant ImmunotherapyMichelle M Dugan, Kate E Beekman, Danielle K DePalo, et al.
The American Journal of Dermatopathology|March 20, 2026
Associations Between Pigmentation and the Clinicopathologic and Immune Landscape of MelanomaHelana Ghali, Ayah N Al-Bzour, Aleena Boby, et al.
Journal of the National Cancer Institute|June 15, 2026
Utility of recurrence-based surrogate endpoints for survival in adjuvant cancer trials: evidence from melanomaSophie E Orme, Serigne N Lo, Robyn P Saw, et al.
Annals of Surgical Oncology|November 22, 2024
Impact of Social Determinants of Health on Melanoma Nodal Surveillance in a Multi-institutional CohortKelsey B Montgomery, M Chandler McLeod, Danielle K DePalo, et al.
Annals of Surgical Oncology|December 8, 2025
ASO Visual Abstract: Recurrence and Survival Outcomes in Patients with Primary Merkel Cell Carcinoma with Positive, Negative or Not Performed Sentinel Lymph Node BiopsyMichelle M Dugan, Caitlyn Balsay-Patel, Nicholas Chin, et al.
Annals of Surgical Oncology|December 11, 2024
ASO Visual Abstract: Impact of Social Determinants of Health on Melanoma Nodal Surveillance in a Multi-Institutional CohortKelsey B Montgomery, M Chandler McLeod, Danielle K DePalo, et al.
Annals of Surgical Oncology|October 31, 2025
Recurrence and Survival Outcomes in Patients with Primary Merkel Cell Carcinoma with Positive, Negative, or Not Performed Sentinel Lymph Node BiopsyMichelle M Dugan, Caitlyn Balsay-Patel, Nicholas Chin, et al.
Cancer|November 10, 2024
A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first-line treatment for patients with melanoma in-transit metastasesDanielle K DePalo, Michelle M Dugan, Syeda Mahrukh Hussnain Naqvi, et al.
Pageof 4